Abstract:Baculovirus has been widely used for the production of recombinant proteins in insect cells. The extremely high yield by baculovirus-infected insect cells or larvae makes it an attractive tool for pharmaceutical protein production. Since the finding that baculovirus can efficiently transduce mammalian cells, the applications of baculovirus have been greatly expanded. Although AcMNPV (Autographa californica multiple NPV) fails to replicate in vertebrate cells, it does express alien genes with levels of expression that are dependent on the strength of the promoter used to drive transcription of the foreign gene. Following these findings, subsequent studies have rapidly expanded the list of permissive cells that include cell lines originating from human, rodent, porcine, bovine and even fish sources. Many tries have been done to study the mechanism of baxulovirus entry into mammalian cells, but the events responsible for virus uptake and detailed mechanisms of intracellular movement and nuclear entry of the virus are still largely unknown. The application of modified baculoviruses for in vivo gene delivery has also been demonstrated. In contrast to other commonly used viral vectors, baculoviruses have the unique property of being incapable of initiating a replication cycle and producing infectious virus in mammalian cells. The AcMNPV genome is large, thus rendering the virus flexibility to carry multiple genes or large inserts. The recombinant viruses can be readily constructed and produced to high titers simply by infecting insect cells, initiate little to none microscopically observable cytopathic effects on mammalian cells and have a good biosafety profile. These attributes will undoubtedly lead to the increased application and continued development of this system for efficient gene delivery into mammalian cells.

Progress of studies and application on baculovirus expression vector system

New Techniques for Insect Baculovirus Expression System

[Progress in vaccine development based on baculovirus expression vector system].

Construction of the Ie1-Bacmid Expression System and Its Use to Express Egfp and Bmago2 in Bmn Cells

Genetic engineering of baculovirus-insect cell system to improve protein production

Construction of a BmNPV Polyhedrin-Plus Bac-to-Bac Baculovirus Expression System for Application in Silkworm, Bombyx Mori

Proteolysis of Recombinant Proteins in the Baculovirus Expression Vector System and the Countermeasures

The Progress in Glycosylation of Recombinant Protein Expressed by Baculovirus-insect System

Development of Baculovirus as Vaccine Vectors

Thirty years of baculovirus-insect cell protein expression: from dark horse to mainstream technology.

Development of a rapid and efficient BmNPV baculovirus expression system for application in mulberry silkworm, Bombyx mori

Application of Baculovirus Expression Vector System (BEVS) in Vaccine Development

Construction of a BmNPV Polyhedrin-plus Bac-to-Bac System for the Silkworm,Bombyx mori

Multi-Gene Recombinant Baculovirus Expression Systems: From Inception to Contemporary Applications

The Biosafety of Recombinant Baculovirus Insecticides

Insect Expression Systems and Their Application in Antibody Engineering

A novel application of baculovirus in mammalian gene therapy]

YBac: A novel and smple baculovirus system for heterologous protein production in <i>Spodoptera frugiperda</i> 9 (Sf9) cells

YBac: A novel and simple baculovirus system for heterologous protein production in <i>Spodoptera frugiperda</i> 9 (Sf9) cells

Primary Studies on Regulable Baculovirus Expression System

Application and research progress of MultiBac: A review